William Kridel Jr., J.D.Chairman and Managing Director, Ferghana Partners
Shamram Hejazi, Ph.D.Venture Partner, BioAdvance
Bernard Lee, Ph.D.Managing Director, Blackrock
Charlie Gersbach, Ph.D.Principal Investigator, Duke University Cancer Center
Jianqing Fan, Ph.D.Operations Research and Financial Engineering, Princeton University
Han Liu, Ph.D.Operations Research and Financial Engineering, Princeton University
Mr. Kridel is the president and founder of Ferghana Partners, a specialist healthcare investment bank. Previously, Mr. Kridel was Managing Director at BZW, the merchant banking arm of Barclays. After the sale of The Kridel Group to Peers & Company, Mr. Kridel ran all European operations from the Paris office of this affiliate of the Long Term Credit Bank of Japan. From 1971-1977, Mr. Kridel was Vice President of the International Corporate Finance Department at Baring Bros. & Co in London and Paris. From 1970-1971, Mr. Kridel worked in the International Finance and Acquisition group at Banque Paribas in Paris. Mr. Kridel graduated with a BA from Yale and JD from Columbia. He qualified as a US attorney and has license to practice before before many bars, including the New York State, Patent Court and US Supreme Court.
Yale University (BA)
Columbia Law School (JD)
Dr. Hejazi is a life science investor and venture partner in BioAdvance. He has experience with both early stage and large global companies and is currently board member of for Infrascan, Inc., Optofluidics, Inc., WellTrackOne Inc., HealthQX LLC (Observer), Enzium, Inc., and Leversense LLC. Previously, Dr. Hejazi was President of Kodak’s Life Science Division, where he global responsibility for R&D, manufacturing, operations, sales, marketing and service. Previously, he was instrumental in establishing the Siemens corporate medical venture unit, as well as the acquisition of Shared Medical Systems. Dr. Hejazi also founded Zargis Medical Corporation, a medical device maker sold to 3M. He is currently James Wei Visiting Professor of Entrepreneurship at Princeton University.
Stanford University (Executive Business Education)
Bernard is a former Blackrock managing director with extensive experience handling middle market PE deals for large global healthcare firms. Bernard is also founder and CEO of HedgeSPA, a fund which developed a novel sophisticated predictive analytics model. Previously, Bernard was a research fellow and later professor at the International Trading Institute at Singapore Management University. Bernard holds graduate degrees in finance and statistics from Princeton, Stanford, and Imperial College London. Bernard is a Board Member for the Stanford Club of San Francisco.
Princeton University (BA)
Imperial College London (Ph.D. in Quantitative Finance)
Stanford University (MS)
Dr. Gersbach is Principal Investigator at Duke Cancer Institute, Associate Professor of Orthopedic Surgery, Scientific Board Member of Editas Medicine Inc.
Dr. Fan is a financial econometrician, statistician, and data scientist. He chaired the Department of Operations Research and Financial Engineering at the Princeton University from 2012 to 2015. Dr. Fan is the winner of Morningside Gold Medal for Applied Mathematics (2007) and the COPSS Presidents Award (2000), the most prestigious award in applied statistics. His research interests include data science, finance, machine learning, computational biology, non-parametric modeling, nonlinear time series, and longitudinal and functional data analysis. Dr. Fan is currently Frederick L. Moore '18 Professor of Finance at Princeton.
UC Berkeley (Ph.D. in Statistics)
Fudan University (Bachelor of Science)
Dr. Liu is a professor at Princeton University’s Department of Operations Research and Financial Engineering, and will serve purely as an academic advisor to Thessalus. He received a joint Ph.D. in Machine Learning and Statistics from Carnegie Mellon University with thesis advisors John Lafferty and Larry Wasserman. Dr. Liu has substantial industry experience designing machine algorithms for multiple hedge funds and PE firms in New York and Chicago. His current research exploits computation and data as a lens to explore science and machine intelligence. Dr. Liu became involved with Thessalus when he realized the untapped potential in a data-driven approach to healthcare investment.
Carnegie Mellon University (Ph.D. in Statistics)
Carnegie Mellon University (MS), University of Toronto (MS)